References
1. Armstrong AW, Read C. Pathophysiology, Clinical Presentation, and
Treatment of Psoriasis: A Review. Jama. 2020 May 19;323(19):1945-60.
2. Wang X, Liu Q, Wu L, Nie Z, Mei Z. Risk of non-melanoma skin cancer
in patients with psoriasis: An updated evidence from systematic review
with meta-analysis. Journal of Cancer. 2020;11(5):1047.
3. Hannuksela-Svahn A, Pukkala E, Läärä E, Poikolainen K, Karvonen J.
Psoriasis, its treatment, and cancer in a cohort of Finnish patients.
Journal of investigative dermatology. 2000 Mar 1;114(3):587-90.
4. Geller S, Xu H, Lebwohl M, Nardone B, Lacouture ME, Kheterpal M.
Malignancy risk and recurrence with psoriasis and its treatments: a
concise update. American journal of clinical dermatology. 2018 Jun
1;19(3):363-75.
5. Archier E, Devaux S, Castela E, Gallini A, Aubin F, Le Maître M,
Aractingi S, Bachelez H, Cribier B, Joly P, Jullien D. Carcinogenic
risks of psoralen UV‐A therapy and narrowband UV‐B therapy in chronic
plaque psoriasis: a systematic literature review. Journal of the
European Academy of Dermatology and Venereology. 2012 May;26:22-31.